706 results on '"Gilkeson, Gary S"'
Search Results
202. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus
203. Absence of functional alternative complement pathway alleviates lupus cerebritis
204. Decay-Accelerating Factor Ameliorates Systemic Autoimmune Disease in MRL/lpr Mice via Both Complement-Dependent and -Independent Mechanisms
205. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis
206. In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells.
207. Role of MHC-Linked Genes in Autoantigen Selection and Renal Disease in a Murine Model of Systemic Lupus Erythematosus
208. Regulation of Fli1 gene expression and lupus
209. Nephritogenic Anti-DNA antibodies regulate gene expression in MRL/lprmouse glomerular mesangial cells
210. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice
211. Developmental Immunotoxicity of Trichloroethylene (TCE): Studies in B6C3F1 Mice
212. Vitamin D deficiency in systemic lupus erythematosus
213. Autoimmune Alterations Induced by the New Zealand BlackLbw2Locus in BWF1 Mice
214. Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid
215. Peroxisome Proliferation-Activated Receptor (PPAR)γ Is Not Necessary for Synthetic PPARγ Agonist Inhibition of Inducible Nitric-Oxide Synthase and Nitric Oxide
216. Genetic polymorphisms in tumor necrosis factor (TNF)-α and TNF-β in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1α-889 C/T polymorphism
217. Enrichment of Anti-Glomerular Antigen Antibody-Producing Cells in the Kidneys of MRL/MpJ-Faslpr Mice
218. Nitric Oxide Induces Apoptosis in Spleen Lymphocytes from MRL/lpr Mice
219. Nitric Oxide Induces Apoptosis in Spleen Lymphocytes from MRL/lpr Mice
220. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice
221. Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice
222. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse
223. Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice
224. Risk factors for development of systemic lupus erythematosus
225. Mediators of injury in lupus nephritis
226. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: A population-based, case-control study in the Southeastern United States
227. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population-based, case-control study
228. Peroxisome proliferator–activated receptor γ agonists: Potential use for treating chronic inflammatory diseases
229. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase
230. Use of Genetic Knockouts to Modulate Disease Expression in a Murine Model of Lupus, MRL/lpr Mice
231. Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lprMice
232. Hemorrhage and Thrombus Formation in Early Experimental Osteonecrosis
233. Immunoglobulin GM and KM Allotypes in Systemic Lupus erythematosus
234. Peroxynitrite Formation and Decreased Catalase Activity in Autoimmune MRL-lpr/lpr Mice
235. Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-γ Agonists
236. Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B
237. Prospective Measure of Serum 3-Nitrotyrosine Levels in Systemic Lupus Erythematosus: Correlation with Disease Activity
238. Effects of Bacterial DNA on Cytokine Production by (NZB/NZW)F1 Mice
239. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus
240. Soluble CD16 in the Treatment of Murine Lupus Nephritis
241. Modulation of renal disease in lupus mice deficient in complement component C3
242. Amelioration of renal disease in lupus mice genetically deficient in complement factor B
243. Nitrosylation of Blood Hemoglobin and Renal Nonheme Proteins in Autoimmune MRL-lpr/lpr Mice
244. Anticardiolipin Antibodies and Osteonecrosis of the Femoral Head
245. Effect of Late Modulation of Nitric Oxide Production on Murine Lupus
246. Differences in Vϰ gene utilization and VH CDR3 sequence among anti-DNA from C3H-lpr mice and lupus mice with nephritis
247. A Pathogenetic Role for TNFα in the Syndrome of Cachexia, Arthritis, and Autoimmunity Resulting from Tristetraprolin (TTP) Deficiency
248. RETROPERITONEAL FIBROSIS
249. The Influence of Variable-Region Somatic Mutations on the Specificity and Pathogenicity of Murine Monoclonal Anti-DNA Antibodies
250. MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.